par Bonnefoi, Herve;Litière, Saskia;Piccart-Gebhart, Martine ;MacGrogan, Gaetan;Fumoleau, Pierre;Brain, Etienne;Petit, Thierry;Rouanet, Philippe;Jassem, Jacek;Moldovan, Cristian;Bodmer, Alexandre;Zaman, Khalil;Cufer, Tanja;Campone, Mario;Luporsi, Élisabeth E.;Malmström, Per Olof P.;Werutsky, Gustavo;Bogaerts, Jan;Bergh, Jonas;Cameron, David A
Référence Annals of oncology, 25, 6, page (1128-1136)
Publication Publié, 2014
Référence Annals of oncology, 25, 6, page (1128-1136)
Publication Publié, 2014
Article révisé par les pairs
Titre: |
|
Auteur: | Bonnefoi, Herve; Litière, Saskia; Piccart-Gebhart, Martine; MacGrogan, Gaetan; Fumoleau, Pierre; Brain, Etienne; Petit, Thierry; Rouanet, Philippe; Jassem, Jacek; Moldovan, Cristian; Bodmer, Alexandre; Zaman, Khalil; Cufer, Tanja; Campone, Mario; Luporsi, Élisabeth E.; Malmström, Per Olof P.; Werutsky, Gustavo; Bogaerts, Jan; Bergh, Jonas; Cameron, David A |
Informations sur la publication: | Annals of oncology, 25, 6, page (1128-1136) |
Statut de publication: | Publié, 2014 |
Sujet CREF: | Hématologie |
Cancérologie | |
Mots-clés: | Breast cancer |
Landmark analysis | |
Neoadjuvant chemotherapy | |
Pathological complete response | |
TP53 | |
MeSH keywords: | Adult |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy -- metabolism -- mortality | |
Carcinoma, Ductal, Breast -- drug therapy -- metabolism -- mortality | |
Chemotherapy, Adjuvant -- mortality | |
Disease-Free Survival | |
Female | |
Humans | |
Middle Aged | |
Neoadjuvant Therapy -- mortality | |
Prognosis | |
Proportional Hazards Models | |
Treatment Outcome | |
Tumor Suppressor Protein p53 -- biosynthesis | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdu118 | |
info:pii/mdu118 | |
info:scp/84903277747 | |
info:pmid/24618153 |